April 24, 2018 / 12:46 PM / 5 months ago

BRIEF-China Biologic Says Excluding Financial Results Of Tianxinfu, Q1 Sales To Grow About 2% In RMB

April 24 (Reuters) - China Biologic Products Holdings Inc :

* CHINA BIOLOGIC PRODUCTS HOLDINGS - EXCLUDING FINANCIAL RESULTS OF TIANXINFU, TOTAL SALES IN Q1 OF 2018 EXPECTED TO GROW ABOUT 2% IN RMB TERMS

* CHINA BIOLOGIC PRODUCTS - INCLUDING TIANXINFU'S CONTRIBUTION, TOTAL SALES FOR Q1 2018 IS EXPECTED TO GROW APPROXIMATELY 13% IN RMB TERMS

* CHINA BIOLOGIC PRODUCTS HOLDINGS- EXCLUDING TIANXINFU RESULTS, Q1 NON-GAAP ADJUSTED NET INCOME EXPECTED TO DECLINE 12-14% Y-O-Y IN RMB TERMS

* CHINA BIOLOGIC - INCLUDING TIANXINFU'S CONTRIBUTION, NON-GAAP ADJUSTED. NET INCOME FOR Q1 2018 IS EXPECTED TO GROW 1% TO 3% YEAR OVER YEAR IN RMB TERMS

* CHINA BIOLOGIC - ONGOING REFORM HEADWINDS INITIATED IN 2017 IN CHINA'S HEALTHCARE MARKET FURTHER NEGATIVELY IMPACTED Q1 SALES REVENUE, PROFIT GROWTH Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below